Q2 Earnings Estimate for ADAP Issued By Leerink Partnrs
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Investment analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for shares of Adaptimmune Therapeutics in a research note issued on Tuesday, May 13th. Leerink Partnrs analyst J. Chang now expects that the biotechnology company will post earnings of ($0.09) per share for the […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Investment analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for shares of Adaptimmune Therapeutics in a research note issued on Tuesday, May 13th. Leerink Partnrs analyst J. Chang now expects that the biotechnology company will post earnings of ($0.09) per share for the […]
